Status:
COMPLETED
Effects of Cranberry Extractive on the Lipid Profiles in Subjects With Type 2 Diabetes
Lead Sponsor:
Taichung Veterans General Hospital
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
50-75 years
Phase:
PHASE3
Brief Summary
Cranberry, containing flavonoids, is effective on improvement of lipid profiles in non-diabetic subjects. The Hypothesis of is to assess the effect of cranberry on lipid profiles in type 2 diabetic pa...
Detailed Description
Hypercholesterolemia is a notorious risk factor for cardiovascular disease. It had been reported cranberry consumption increased nearly 8% of circulating high-density lipoprotein (HDL) cholesterol lev...
Eligibility Criteria
Inclusion
- type 2 diabetic subjects
- age between 50 and 75 years
Exclusion
- glycosylated hemoglobin (HbA1c) less than 7% or more than 10%;
- triglyceride more than 4.5 mmol/L;
- current insulin treatment;
- change of the medications for anti-diabetes, hypertension, hyperlipidemia and anti-platelet in recent four weeks;
- abnormal renal function (serum creatinine \> 177 μmol/L;
- abnormal liver function test results (more than two-fold upper limit of normal range);
- severe systemic disease such as immune disorder, cancer, acute or chronic inflammation disease;
- smoking in recent 1 year;
- alcoholism (more than two drinks daily);
- using steroid or drugs with unknown components;
- pregnancy or breast-feeding.
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2006
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00695526
Start Date
May 1 2006
End Date
October 1 2006
Last Update
June 17 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
outpatient clinic of the Division of Endocrinology and Metabolism in Taichung Veterans General Hospital
Taichung, Taiwan, 407